International Journal of Cancer Management

Published by: Kowsar

Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran

Mehrdad Payandeh 1 , Masoud Sadeghi 2 , 3 , * and Edris Sadeghi 2 , 3
Authors Information
1 Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2 Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
3 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: December 28, 2015, 8 (6); e4038
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: September 27, 2015
  • Accepted: November 7, 2015
  • DOI: 10.17795/ijcp-4038

To Cite: Payandeh M, Sadeghi M, Sadeghi E. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran, Int J Cancer Manag. 2015 ; 8(6):e4038. doi: 10.17795/ijcp-4038.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Karbakhsh M, Dabbagh N, Shabani A, Tabibi A, Akhavizadegan H. Age at diagnosis in bladder cancer: does opium addiction play a role? Asian Pac J Cancer Prev. 2013; 14(8): 4723-5[PubMed]
  • 2. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010; 13(2): 143-6[PubMed]
  • 3. Groeneveld AE, Marszalek WW, Heyns CF. Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa. Br J Urol. 1996; 78(2): 205-8[PubMed]
  • 4. Xu C, Zhang Z, Wang H, Song Q, Wei R, Yu Y, et al. A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging. PLoS One. 2014; 9(4)[DOI][PubMed]
  • 5. Bhat A, Heinzel A, Mayer B, Perco P, Muhlberger I, Husi H, et al. Protein interactome of muscle invasive bladder cancer. PLoS One. 2015; 10(1)[DOI][PubMed]
  • 6. Al-Samawi AS, Aulaqi SM. Urinary bladder cancer in yemen. Oman Med J. 2013; 28(5): 337-40[DOI][PubMed]
  • 7. Yu G, Yao W, Xiao W, Li H, Xu H, Lang B. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. J Exp Clin Cancer Res. 2014; 33: 779[DOI][PubMed]
  • 8. Rezaianzadeh A, Mohammadbeigi A, Mobaleghi J, Mohammadsalehi N. Survival analysis of patients with bladder cancer, life table approach. J Midlife Health. 2012; 3(2): 88-92[DOI][PubMed]
  • 9. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, et al. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8)[DOI][PubMed]
  • 10. Kantor AF, Hartge P, Hoover RN, Fraumeni JF. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res. 1988; 48(13): 3853-5[PubMed]
  • 11. Rambau PF, Chalya PL, Jackson K. Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients. Infect Agent Cancer. 2013; 8(1): 19[DOI][PubMed]
  • 12. Murase T, Takashi M, Aota Y, Shimoji T, Miyake K, Mitsuya H. [Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases]. Hinyokika Kiyo. 1985; 31(4): 615-21[PubMed]
  • 13. Kong CH, Singam P, Hong GE, Cheok LB, Azrif M, Tamil AM, et al. Clinicopathological features of bladder tumours in a single institution in Malaysia. Asian Pac J Cancer Prev. 2010; 11(1): 149-52[PubMed]
  • 14. Matalka I, Bani-Hani K, Shotar A, Bani Hani O, Bani-Hani I. Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Singapore Med J. 2008; 49(10): 790-4[PubMed]
  • 15. Suo S, Chen X, Ji X, Zhuang Z, Wu L, Yao Q, et al. Investigation of the non-Gaussian water diffusion properties in bladder cancer using diffusion kurtosis imaging: a preliminary study. J Comput Assist Tomogr. 2015; 39(2): 281-5[DOI][PubMed]
  • 16. Sevcenco S, Haitel A, Ponhold L, Susani M, Fajkovic H, Shariat SF, et al. Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity. PLoS One. 2014; 9(9)[DOI][PubMed]
  • 17. Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol. 2003; 169(5): 1697-701[DOI][PubMed]
  • 18. Keymoosi H, Gheytanchi E, Asgari M, Shariftabrizi A, Madjd Z. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev. 2014; 15(5): 2013-20[PubMed]
  • 19. Kalantari MR, Ahmadnia H. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification. Urol J. 2007; 4(4): 230-3[PubMed]
  • 20. Lin HY, Yang MC, Huang CH, Wu WJ, Yu TJ, Lung FW. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. Urol Oncol. 2013; 31(7): 1231-41[DOI][PubMed]
  • 21. Monfared H, Ziaee SA, Hashemitabar M, Khayatzadeh H, Kheyrollahi V, Tavallaei M, et al. Co-regulated expression of TGF-beta Variants and miR-21 in bladder cancer. Urol J. 2013; 10(3): 981-7[PubMed]
  • 22. Asadzadeh J, Asadi MH, Shakhssalim N, Rafiee MR, Kalhor HR, Tavallaei M, et al. A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors. Urol J. 2012; 9(3): 574-80[PubMed]
  • 23. Mohseni MG, Zand S, Aghamir SM. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Urol J. 2004; 1(4): 250-2[PubMed]
  • 24. Sun L, Zhang W, Liu H, Yuan J, Liu W, Yang Y. Computed tomography imaging-guided percutaneous argon-helium cryoablation of muscle-invasive bladder cancer: initial experience in 32 patients. Cryobiology. 2014; 69(2): 318-22[DOI][PubMed]
  • 25. Kwon T, Jeong IG, Lee J, Lee C, You D, Hong B, et al. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting. J Cancer Res Clin Oncol. 2015; 141(1): 169-76[DOI][PubMed]
  • 26. Ahmadi M, Ranjbaran H, Amiri MM, Nozari J, Mirzajani MR, Azadbakht M, et al. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran. Asian Pac J Cancer Prev. 2012; 13(10): 5053-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments